Beyond gastrointestinal symptom burden: Integrating fecal calprotectin into a multimodal safety strategy before initiating bimekizumab in hidradenitis suppurativa
Beyond gastrointestinal symptom burden: Integrating fecal calprotectin into a multimodal safety strategy before initiating bimekizumab in hidradenitis suppurativa. // Journal of the American Academy of Dermatology. – URL: https://www.sciencedirect.com/science/article/pii/S0190962226032871?dgcid=rss_sd_all
Beyond gastrointestinal symptom burden: Integrating fecal calprotectin into a multimodal safety strategy before initiating bimekizumab in hidradenitis suppurativa. Journal of the American Academy of Dermatology. https://www.sciencedirect.com/science/article/pii/S0190962226032871?dgcid=rss_sd_all
“Beyond gastrointestinal symptom burden: Integrating fecal calprotectin into a multimodal safety strategy before initiating bimekizumab in hidradenitis suppurativa.” Journal of the American Academy of Dermatology.
@article{article119092,
title = {Beyond gastrointestinal symptom burden: Integrating fecal calprotectin into a multimodal safety strategy before initiating bimekizumab in hidradenitis suppurativa},
journal = {Journal of the American Academy of Dermatology},
url = {https://www.sciencedirect.com/science/article/pii/S0190962226032871?dgcid=rss_sd_all}
}